Consilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum94773MiscellaneousAntibiotic stewardship program for inpatient care. Clinical guidelines for Moscow hospitalsYakovlevS. Vantimicrob@yandex.ruZhuravlevaM. V-ProtsenkoD. N-BeloborodovV. B-BrikoN. I-BrusinaE. B-GusarovV. G-EliseevaE. V-ZamyatinM. N-ZyryanovS. K-KukesV. G-PopovD. A-SidorenkoS. V-SuvorovaM. P-I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian FederationInterregional Public Organization “Alliance Clinical Chemioterapico and Microbiologists”N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian FederationN.I.Pirogov City Clinical Hospital №1 of the Department of Health of Moscow119049, Russian Federation, Moscow, Leninskii pr-t., d. 10, korp. 5Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian FederationNational Association of professionals in infection control related to the provision of medical care (NAPIC)Kemerovo State Medical University of the Ministry of Health of the Russian FederationN.I.Pirogov National Medical and Surgical Center of the Ministry of Health of the Russian FederationPacific State Medical University Ministry of Health of the Russian FederationPeople’s Friendship University of RussiaCity Clinical Hospital №24 of the Department of Health of MoscowA.N.Bakulev Scientific Centre of Cardiovascular Surgery of the Ministry of Health of the Russian FederationResearch Institute of Childhood InfectionsI.I.Mechnikov State Northwestern Medical University of the Ministry of Health of the Russian Federation17072017197-1155128122021Copyright © 2017, Consilium Medicum2017[Стратегия и тактика применения антимикробных средств в лечебных учреждениях России: Российские национальные рекомендации. Под ред. В.С.Савельева, Б.Р.Гельфанда, С.В.Яковлева. М.: Боргес, 2012. www.antimicrob.net][Яковлев С.В., Суворова М.П., Елисеева Е.В. Стратегические и тактические вопросы рационального применения антибактериальных препаратов в стационаре. В кн.: Рациональная антимикробная фармакотерапия: руководство для практикующих врачей. Изд. 2-е, перераб. и доп. М.: Литтерра, 2015; с. 421-36.][Christiansen K.J et al. In vitro activity of doripenem and other carbapenems against contemporary Gram - negative pathogens isolated from hospitalised patients in the Asia - Pacific region: results of the COMPACT Asia - Pacific Study. Int J Antimicrob Agents 2010; 36 (60): 501-6.][Gales A.C et al. Antimicrobial activity of doripenem against Gram - negative pathogens: results from INVITA-A-DORI Brazilian study. Braz J Infect 2011; 15 (6).][Fukuda S et al. The annual changes in antimicrobial susceptibility test results of Pseudomonas aeruginosa isolates from the Kinki district. Jpn J Antibiot 2016 Apr; 69 (2): 101-10.][Яковлев С.В., Суворова М.П., Белобородов В.Б. и др., члены исследовательской группы ЭРГИНИ. Распространенность и клиническое значение нозокомиальных инфекций в лечебных учреждениях России: исследование ЭРГИНИ. Антибиотики и химиотерапия. 2016; 61 (5-6): 32-42.][Стратегия и тактика рационального применения антимикробных средств в амбулаторной практике. Российские практические рекомендации. Под ред. С.В.Яковлева, С.В.Сидоренко, В.В.Рафальского, Т.В.Спичак. М.: Пре100принт, 2014. www.antimicrob.net][Dellit T.H, Owens R.C, Mc Gowan J.E et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship. Clin Infect Dis 2007; 44: 159-77.][Shlaes D.M, Gerding D.N, John J.F et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the Prevention of Antimicrobial Resistance in Hospitals. Clin Infect Dis 1997; 25: 584-99.][Drew R.H. Antimicrobial Stewardship Programs: How to Start and Steer a Successful Program. J Manag Care Pharm 2009; 15 (Suppl. 2): S18-S23.][Pollack L.A, Srinivasan A. Core Elements of Hospital Antibiotic Stewardship Programs From the Centers for Disease Control and Prevention. Clin Infect Dis 2014; 59 (S3): S97-100.][Nagel J.L, Stevenson J.G, Eiland E.H 3rd, Kaye K.S. Demonstrating the Value of Antimicrobial Stewardship Programs to Hospital Administrators. Clin Infect Dis 2014; 59 (S3): S146-53.][De Pestel D.D, Eiland E.H 3rd, Lusardi K et al. Assessing Appropriateness of Antimicrobial Therapy: In the Eye of the Interpreter. Clin Infect Dis 2014; 59 (S3): S154-61.][Bumpass J.B, Mc Daneld P.M, De Pestel D.D et al. Outcomes and Metrics for Antimicrobial Stewardship: Survey of Physicians and Pharmacists. Clin Infect Dis 2014; 59 (S3): S108-11.][Яковлев С.В. Необходимость внедрения в ЛПУ программ сдерживания антибиотикорезистентности. Здоровье нации. 2013; 3 (26): 22-4.][Яковлев С.В., Проценко Д.Н., Шахова Т.В. и др. Антибиотикорезистентность в стационаре: контролируем ли мы ситуацию? Антибиотики и химиотерапия 2010; 55 (1-2): 50-8.][Елисеева Е.В., Гайнуллина Ю.И., Гельцер Б.И. Управление качеством в сфере применения антибактериальных препаратов. Владивосток: Дальнаука, 2010.][Приказ Министерства здравоохранения и социального развития Российской Федерации (Минздравсоцразвития России) от 22 ноября 2010 г. №1022н, г. Москва, «Об утверждении Порядка оказания медицинской помощи населению по профилю «Клиническая фармакология».][Kollef M.H, Sherman G, Ward S, Fraser V.J. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115 (2): 462-74.][Iregui M, Ward S, Sherman G et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator - associated pneumonia. Chest 2002; 122 (1): 262-8.][Yakovlev S, Gelfand B, Protsenko D. Ventilator - associated pneumonia in patients with truma: risk factors concerning mortality [abstract P1603]. 13th European Congress of Clinical Microbiology and Infectious Diseases, Glasgow, May 10-13, 2003. Clin Microbiol Infect 2003; 9 (6).][Проценко Д.Н., Ярошецкий А.И., Гельфанд Б.Р. и др. Протокол антибактериальной терапии нозокомиальной пневмонии при проведении искусственной вентиляции легких: эффективность внедрения. Инфекции и антимикробная терапия. 2005; 7 (2): 15-20.][Owens R.C, Fraser G.L, Stogsdill P. Antimicrobial stewardship programs as a means to optimize antimicrobial use. Pharmacotherapy 2004; 24: 896-908.][Feucht C.L, Rice L.B. An interventional program to improve antibiotic use. Ann Pharmacother 2003; 37: 646-51.][Fraser G.L, Stogsdill P, Dickens J.D Jr et al. Antibiotic optimization: an evaluation of patient safety and economic outcomes. Arch Intern Med 1997; 157: 1689-94.][Lautenbach E, Patel J.B, Bilker W.B et al. Extended - spectrum b - lactamase - producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001; 32: 1162-71.][Lin M.F, Huang M.L, Lai S.H. Risk factors in the acquisition of extended - spectrum beta - lactamase Klebsiella pneumoniae: a case - control study in a district teaching hospital in Taiwan. J Hosp Infect 2003; 53: 39-45.][Patterson J.E, Hardin T.C, Kelly C.A et al. Association of antibiotic utilization measures and control of multiple - drug resistance in Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2000; 21: 4558.][Lesch C.A, Itokazu G.S, Danziger L.H, Weinstein R.A. Multi - hospital analysis of antimicrobial usage and resistance trends. Diagn Microbiol Infect Dis 2001; 41: 149-54.][Di Nubile M.F et al. Bowel colonization with resistant gram - negative bacilli after antimicrobial therapy of intra - abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy. Eur J Clin Microbiol Infect Dis 2005; 24: 443-9.][Cao B, Wang H, San H et al. Risk factors and clinical outcames of nosocomial multi - drug resistant nosocomial Pseudomonas aeruginosa infections. J Hosp Inf 2004; 57 (2): 112-8.][Goldstein E, Citron D.M, Peraino V et al. Introduction of Ertapenem into a Hospital Formulary: Effect on Antimicrobial Usage and Improved In Vitro Susceptibility of Pseudomonas aeruginosa. Antimicrob Ag Chemother 2009; 53 (12): 5122-26.][Goldstein E, Periano V, Hammer-Reig L et al. Carbapenem stewardship: sustained, improved imipenem susceptibility of Pseudomonas aeruginosa correlated with eight - years of increased ertapenem usage.][Nicolau D.P, Carmeli Y, Crank C.W et al. Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence. Int J Antimicrob Agents 2012; 39: 11-5.][Petros A. Psathas, Stability of Doripenem in Vitro in Representative Infusion Solutions and Infusion Bags. Clinical Therapeutics 2008; 30 (11).][Crandon J.L, Sutherland C, Nicolau D.P. Stability of doripenem in polyvinyl chloride bags and elastomeric pumps. Am J Health - Syst Pharm 2010; 67 (15).][Keel R.A, Sutherland C.A, Crandon J.L, Nicolau D.P. Stability of doripenem, imipenem and meropenem at elevated room temperatures. Int J Antimicrob Agents 2011; 37 (2): 184-5.][Craig W.A. Pharmacokinetic/pharmacodynamic parameters: Rationale for antimicrobial dosing of mice and men. Clin Infect Dis 1998; 26: 1-12.][Bratzler D.W, Houck P.M. Antimicrobial prophylaxix for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004; 38: 1706-15.][Bratzler D.W, Dellinger E.P, Olsen K.M et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health - Syst Pharm 2013; 70: 195-283.][Яковлев С.В. Высокотехнологичная периоперационная антибиотикопрофилактика в контексте хирургической концепции Fast Track. Доктор.ру. Анестезиология и реаниматология. Мед. реабилитация. 2016; 12 (1): 43-8.][Burke J.F. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 1961; 50: 161-8.][Хирургические инфекции кожи и мягких тканей: Российские национальные рекомендации. Под ред. Б.Р.Гельфанда, А.О.Жукова, А.Б.Земляного, С.В.Яковлева. М.: Боргес, 2009.][Anderson D.J, Kaye K.S, Classen D et al. Strategies to Prevent Surgical Site Infections in Acute Care Hospitals. Infect Control Hosp Epidemiol 2008; 29 (Suppl. 1): S51-61.][Hagel S, Scheuerlein H. Perioperative antibiotic prophylaxis and antimicrobial therapy of intra - abdominal infections. Viszeralmedizin 2014; 30: 310-6.][Harbarth S, Samore M.H, Lichtenberg D, Carmelli Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 2000; 101: 2916-21.][Hirokawa F, Hayashi M, Miyamoto Y et al. Evaluation of postoperative antibiotic prophylaxis after liver resection: a randomized controlled trial. Am J Surg 2013; 206: 8-15.][Carignan A, Allard C, Pepin J et al. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. Clin Infect Dis 2008; 46: 1838-43.][Покровский В.И., Акимкин В.Г., Брико Н.И. и др. Национальная концепция профилактики инфекций, связанных с оказанием медицинской помощи, и информационный материал по ее положениям. Н.Новгород: Ремедиум Приволжье, 2012.][Baron E.J, Miller J.M, Weinstein M.P et al. A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2013 Recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clin Infect Dis 2016; 57 (4): e22-e121.][Солодовников В.В., Гайнуллина Ю.И., Елисеева Е.В., Кривелевич В.Я. Современное состояние проблемы и значение службы клинической фармакологии в оптимизации использования антибактериальных лекарственных средств. Проблемы стандартизации в здравоохранении. 2008; 9: 3-7.][Laxminarayan R, Klugman K.P. Communicating trends in resistance using a drug resistance index. BMJ Open 2011; 1: e000135.][Gross P.A, Trish L, Barret R.N et al. Quality standart for the treatment of bacteremia. Infect Control Hosp Epidemiol 1994; 15: 189-92.][SHEA. An approach to the evaluation of quality indicators of the outcome of care in hospitalized patients with a focus in nosocomial infection indicators. Infect Control Hosp Epidemiol 1995; 16: 308-16.][Rodríguez-Baño J, de Cueto M, Retamar P, Gálvez-Acebal J. Current management of bloodstream infections. Expert Rev Anti Infect Ther 2010; 8 (7): 815-29.][Гусаров В.Г., Нестерова Е.Е., Оприщенко И.В. и др. Клинические и фармакоэкономические результаты использования протокола эмпирической антимикробной терапии в многопрофильном стационаре. Вестн. Национального медико - хирургического центра им. Н.И.Пирогова. 2015; 10 (4): 100-3.][Гусаров В.Г., Нестерова Е.Е., Лашенкова Н.Н. и др. Зависимость уровня микробной резистентности от потребления антимикробных препаратов в многопрофильном стационаре. Клин. патофизиология. 2015; 3: 55-49.][NICE quality standard 49. Issued: October 2013. Surgical site infection. guidance.nice.org.uk/qs49.][Gyssens I.C. Quality Measures of Antimicrobal Drug Use. Int J Antimicrob Agents 2001; 17: 9-19.]